Rash maculo-papular and Weakness

Summary:

Weakness is found among people with Rash maculo-papular, especially for people who are male, 60+ old.

The study analyzes which people have Weakness with Rash maculo-papular. It is created by eHealthMe based on reports of 18 people who have Rash maculo-papular from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Rash maculo-papular?

Rash maculo-papular (red area on the skin that is covered with small confluent bumps) is found to be associated with 1,244 drugs and 1,534 conditions by eHealthMe. Check the latest studies of Rash maculo-papular.

What is Weakness?

Weakness is found to be associated with 3,639 drugs and 6,612 conditions by eHealthMe. Check the latest studies of Weakness.



On Jul, 18, 2026

18 people who have Rash Maculo-Papular and Weakness are studied.

Would you have Weakness when you have Rash maculo-papular?

Gender of people who have Rash Maculo-Papular and experienced Weakness *:

  • female: 29.41 %
  • male: 70.59 %

Age of people who have Rash Maculo-Papular and experienced Weakness *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 6.25 %
  • 50-59: 37.5 %
  • 60+: 56.25 %

Common co-existing conditions for these people *:

  1. Stress And Anxiety: 9 people, 50.00%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 50.00%
  3. Malignant Melanoma (skin cancer rises from melancytes): 8 people, 44.44%
  4. Constipation: 6 people, 33.33%
  5. Diarrhea: 6 people, 33.33%
  6. Nausea (feeling of having an urge to vomit): 6 people, 33.33%
  7. Type 2 Diabetes: 6 people, 33.33%
  8. Fever: 5 people, 27.78%
  9. Insomnia (sleeplessness): 5 people, 27.78%
  10. Dry Mouth: 4 people, 22.22%

Common drugs taken by these people *:

  1. Prednisone: 8 people, 44.44%
  2. Benadryl: 8 people, 44.44%
  3. Zofran: 7 people, 38.89%
  4. Sodium Chloride: 7 people, 38.89%
  5. Tylenol: 5 people, 27.78%
  6. Miralax: 5 people, 27.78%
  7. Lipitor: 5 people, 27.78%
  8. Protonix: 5 people, 27.78%
  9. Melatonin: 5 people, 27.78%
  10. Loratadine: 4 people, 22.22%

Common symptoms for these people *:

  1. Urticaria (rash of round, red welts on the skin that itch intensely): 4 people, 22.22%
  2. Lip Swelling: 4 people, 22.22%
  3. Alanine Aminotransferase Increased: 4 people, 22.22%
  4. Aspartate Aminotransferase Increased: 4 people, 22.22%
  5. Blood Bilirubin Increased: 4 people, 22.22%
  6. Blood Creatine Phosphokinase Increased: 4 people, 22.22%
  7. Bone Pain: 4 people, 22.22%
  8. Cellulitis (infection under the skin): 4 people, 22.22%
  9. Dyspnea (difficult or laboured breathing): 4 people, 22.22%
  10. Headache (pain in head): 4 people, 22.22%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Weakness?

- Check whether Weakness is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Weakness:

All the conditions that are associated with Weakness:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Weakness and Rash maculo-papular, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: